Chair of Epidemiology, Department of Sport and Health Sciences, Technical University of Munich, Munich, Germany.
Int J Cancer. 2023 Oct 15;153(8):1459-1471. doi: 10.1002/ijc.34638. Epub 2023 Jul 1.
With improvements in survival after colorectal cancer (CRC), more survivors are at risk of developing a second cancer, particularly in younger populations where CRC incidence is increasing. We estimated the incidence of second primary cancer (SPC) in CRC survivors and its potential risk factors. We identified CRC cases diagnosed between 1990 and 2011 and SPCs until 2013 from nine German cancer registries. Standardized incidence ratios (SIR) and absolute excess risk (AER) per 10 000 person-years were calculated and were stratified by index site: colon cancer (CC) and rectal cancer (RC), age and sex. Cox regression assessed potential SPC risk factors, including primary tumor-related therapy considering death as a competing risk. We included 217 202 primary CRC cases. SPC occurred in 18 751 CRC survivors (8.6%; median age: 69 years). Risk of cancer was significantly higher in CRC survivors than in the general population (SIR males 1.14, 95% confidence interval [CI] 1.12-1.17, AER = 24.7; SIR females 1.20, 95% CI 1.17-1.23, AER = 22.8). Increased risks of SPCs were observed for the digestive system, urinary system and female and male reproductive organs. CRC incidence increased in younger persons (<50 years) and SPC incidence was 4-fold in this group (SIR males 4.51, 95% CI 4.04-5.01, AER = 64.2; SIR females 4.03, 95% CI 3.62-4.48, AER = 77.0). Primary tumor-related factors associated with SPC risk were right-sided cancer and smaller primary tumor size. Treatment and risk of SPC differed for CC (no effect) and RC (lower risk after chemotherapy). CRC survivors have excess risk of developing SPC, with particular characteristics that could guide targeted surveillance.
随着结直肠癌(CRC)患者生存率的提高,越来越多的幸存者面临罹患第二原发癌(SPC)的风险,尤其是在 CRC 发病率不断上升的年轻人群中。本研究旨在评估 CRC 幸存者中 SPC 的发生率及其潜在的危险因素。我们从 9 个德国癌症登记处确定了 1990 年至 2011 年间诊断的 CRC 病例和截至 2013 年的 SPC。通过每 10000 人年的标准化发病比(SIR)和绝对超额风险(AER)来计算,并根据索引部位(结肠癌[CC]和直肠癌[RC])、年龄和性别进行分层。Cox 回归分析评估了潜在的 SPC 危险因素,包括考虑死亡为竞争风险的原发性肿瘤相关治疗。我们纳入了 217202 例原发性 CRC 病例。在 217202 例 CRC 幸存者中发生了 18751 例 SPC(8.6%;中位年龄:69 岁)。CRC 幸存者的癌症风险显著高于一般人群(男性 SIR 为 1.14,95%CI 为 1.12-1.17,AER=24.7;女性 SIR 为 1.20,95%CI 为 1.17-1.23,AER=22.8)。消化系统、泌尿系统和女性及男性生殖器官的 SPC 风险增加。在较年轻的人群(<50 岁)中,CRC 的发病率增加,而在该组中 SPC 的发病率增加了 4 倍(男性 SIR 为 4.51,95%CI 为 4.04-5.01,AER=64.2;女性 SIR 为 4.03,95%CI 为 3.62-4.48,AER=77.0)。与 SPC 风险相关的原发性肿瘤因素为右侧肿瘤和较小的肿瘤大小。CC 患者的治疗与 SPC 风险无关(无影响),RC 患者的化疗后风险降低。CRC 幸存者发生 SPC 的风险增加,具有特定的特征,这可能有助于有针对性的监测。